Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 2, 2007

Lonza Starts Up Small-Scale Facility in China

  • Lonza reports the successful start up of a small-scale plant (SSP) in Nansha Guangzhou, China. After having accomplished a five-day process on schedule, a product was tested and met all the standards and requirements, according to the firm.

    The Nansha facility is designed to accommodate a greater number of reactors including a quality control lab. In the completed first build-out phase, further smaller reactors like distillation and filtration units are installed.

    The plant reportedly is designed for production of quantities from 10 kilograms up to several hundreds of kilograms. This closes the gap between Nansha's kilo lab and commercial production assets to allow complete life-cycle support for pharmaceutical products out of China, continues Lonza. The commercial scale API facility in Nansha is currently under construction and will go online in the second half of 2008.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »